Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia A case report and literature review

被引：3

作者：

Payandeh, Mehrdad ^{[1
]}

Karami, Afshin ^{[2
]}

Karami, Noorodin ^{[3
]}

Masgareh, Jafar Barati ^{[4
]}

机构：

[1] Kermanshah Univ Med Sci, Dept Hematol & Med Oncol, Kermanshah, Iran

[2] Shahid Beheshti Univ Med Sci, Dept Hematol, Tehran, Iran

[3] Shahid Sadoughi Univ Med Sci, Dept Genet, Yazd, Iran

[4] Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran

来源：

BIOMEDICAL RESEARCH AND THERAPY | 2018年 / 5卷 / 08期

关键词：

Immune thrombocytopenia; Prednisolone; Primary ITP; Romiplostim; Splenectomy;

D O I：

10.15419/bmrat.v5i8.465

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Immune thrombocytopenia is characterized by reduced platelet count. This condition occurs in both adults and children. The most common form of thrombocytopenia is primary ITP and autoantibodies are involved in its development. In this study, our patient was a pregnant woman with ITP who showed refractory to prednisolone and splenectomy as first and second line treatment, respectively, but the response to treatment with Romiplostim and platelet count was favorable, and delivery was reported without fetal complications.

引用

页码：2565 / 2571

页数：7

共 27 条

[1] Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases? Data from a Long-Term Observation [J].